How Does BioProtect Protection Work?

The active ingredient in BioProtect polymerizes to all surfaces and is both colorless and odorless.

Think of BioProtect as a layer of electrically charged swords.  When a microorganism comes in contact with the treated surface, the quaternary amine sword punctures the cell membrane and the remnants are then electrocuted.

Since nothing is transferred to the now dead cell, the antimicrobial does not lose it’s strength and the sword is now ready for the next cell to contact it.  (NOTE: Normal cleaning of the treated surfaces is necessary in order for the BioProtect   antimicrobials to continue their effectiveness.  Dirt buildup,  paint, dead microbes, etc. will cover the treatment prohibiting it from killing microorganisms.)


Antibiotics for acute respiratory infections in general practice: comparison of prescribing rates with guideline recommendations


Objective: To compare the current rate of antibiotic prescribing for acute respiratory infections (ARIs) in Australian general practice with the recommendations in the most widely consulted therapeutic guidelines in Australia (Therapeutic Guidelines).

Design and setting: Comparison of general practice activity data for April 2010 – March 2015 (derived from Bettering the Evaluation and Care of Health [BEACH] study) with estimated rates of prescribing recommended by Therapeutic Guidelines.

Main outcome measures: Antibiotic prescribing rates and estimated guideline-recommended rates per 100 encounters and per full-time equivalent (FTE) GP per year for eight ARIs; number of prescriptions nationally per year.

Results: An estimated mean 5.97 million (95% CI, 5.69–6.24 million) ARI cases per year were managed in Australian general practice with at least one antibiotic, equivalent to an estimated 230 cases per FTE GP/year (95% CI, 219–240 cases/FTE/year). Antibiotics are not recommended by the guidelines for acute bronchitis/bronchiolitis (current prescribing rate, 85%) or influenza (11%); they are always recommended for community-acquired pneumonia (current prescribing rate, 72%) and pertussis (71%); and they are recommended for 0.5–8% of cases of acute rhinosinusitis (current prescribing rate, 41%), 20–31% of cases of acute otitis media (89%), and 19–40% cases of acute pharyngitis or tonsillitis (94%). Had GPs adhered to the guidelines, they would have prescribed antibiotics for 0.65–1.36 million ARIs per year nationally, or at 11–23% of the current prescribing rate. Antibiotics were prescribed more frequently than recommended for acute rhinosinusitis, acute bronchitis/bronchiolitis, acute otitis media, and acute pharyngitis/tonsillitis.

Conclusions: Antibiotics are prescribed for ARIs at rates 4–9 times as high as those recommended by Therapeutic Guidelines. Our data provide the basis for setting absolute targets for reducing antibiotic prescribing in Australian general practice.  Source

Rate this blog entry:
When it comes to preventing dementia, not much is ...
The Spread of the Mers-CoV Virus: The Black Death ...


No comments made yet. Be the first to submit a comment
Already Registered? Login Here
Wednesday, 15 August 2018
If you'd like to register, please fill in the username, password and name fields.